Call for Your FREE Evaluation (877) 503-1595

JOHNSON & JOHNSON TRIES TO ADDRESS CRITICAL DRUG SHORTAGE

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

J & J

JOHNSON & JOHNSON TRIES TO ADDRESS CRITICAL DRUG SHORTAGE

Since 2010, ovarian cancer patients have been missing an effective and palatable chemotherapy drug called Doxil.  In 2010, FDA inspectors came upon contamination problems at the Ohio plant, and since then the drug has been in severe shortage.  About 7000 patients a year have used this drug, but by November of 2010, the only factory…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Doxil, J & J, Johnson & Johnson, Overian Cancer,

LEVAQUIN UPDATE

Johnson & Johnson has scored a victory in the Levaquin litigation it has been fighting.  A United States Court of Appeals ruled for the drug giant, reversing a $1.1 million punitive award that a jury had awarded to plaintiff John Schedin. The Court of Appeals states that there was no evidence that Johnson & Johnson…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, J & J, Johnson & Johson, Levaquin,